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Abstract: Pulmonary rehabilitation (PR) reduces the number and duration of hospital 
admissions and readmissions, and improves health-related quality of life in patients with COPD. 
Despite clinical guideline recommendations, under-referral and limited uptake to PR contribute 
to poor treatment access. We reviewed published literature on the effectiveness of interventions 
to improve referral to and uptake of PR in patients with COPD when compared to standard 
care, alternative interventions, or no intervention. The review followed recognized methods. 
Search terms included “pulmonary rehabilitation” AND “referral” OR “uptake” applied to 
MEDLINE, EMBASE, CINAHL, PsycINFO, ASSIA, BNI, Web of Science, and Cochrane 
Library up to January 2018. Titles, abstracts, and full papers were reviewed independently and 
quality appraised. The protocol was registered (PROSPERO # 2016:CRD42016043762). We 
screened 5,328 references. Fourteen papers met the inclusion criteria. Ten assessed referral and 
five assessed uptake (46,146 patients, 409 clinicians, 82 hospital departments, 122 general prac-
tices). One was a systematic review which assessed uptake. Designs, interventions, and scope of 
studies were diverse, often part of multifaceted evidence-based management of COPD. Examples 
included computer-based prompts at practice nurse review, patient information, clinician edu-
cation, and financial incentives. Four studies reported statistically significant improvements in 
referral (range 3.5%–36%). Two studies reported statistically significant increases in uptake 
(range 18%–21.5%). Most studies had methodological and reporting limitations. Meta-analysis 
was not conducted due to heterogeneity of study designs. This review demonstrates the range 
of approaches aimed at increasing referral and uptake to PR but identifies limited evidence of 
effectiveness due to the heterogeneity and limitations of study designs. Research using robust 
methods with clear descriptions of intervention, setting, and target population is required to 
optimize access to PR across a range of settings.
Keywords: health services research, service improvement, access to healthcare, evidence-based 
practice, long-term condition, supervised exercise
Introduction
COPD presents a considerable health challenge. It is estimated that worldwide 
328 million people have COPD and 65 million people live with moderate to 
severe COPD.1 In 2015, COPD accounted for 5% of all deaths globally,2 and 
in the UK, ~1.2 million people and 4.5% of all people aged over 40 years live with 
the condition.3 COPD is likely to be underdiagnosed and prevalence in the UK may be 
rising.3 It compromises individuals’ quality of life and impacts healthcare costs, mostly 
relating to hospital admissions. In 2012, it was estimated to cost the UK National Health 
Service £800 million per annum.4 Pulmonary rehabilitation (PR), providing supervised 
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exercise and education, improves COPD symptoms leading 
to improvements in exercise capacity and quality of life.5 
PR reduces the number and duration of respiratory hospi-
tal admissions experienced by individuals,6 the number of 
readmissions,6,7 and can foster self-management skills.8 It is 
a cost-effective treatment.9
Despite a clear evidence base and guidelines recommend-
ing PR,10,11 it is grossly underutilized in practice worldwide.12 
In England and Wales, for example, the National COPD 
Audit Programme for 2013/14 estimated the prevalence of 
COPD patients eligible for PR to be 446,000; however, only 
68,000 were referred (15% of normative need) of whom 
only 69% attended an initial assessment (10% of normative 
need).13 Utilization may be impacted by availability, referral, 
and uptake but even where places are available they may not 
be utilized. In the East of England in 2014/15, the number of 
available PR places represented only 53.8% of the proposed 
target, but just 73% of these places were taken up.14 There is 
an urgent need to improve referral and uptake to PR both in 
the UK6,13 and globally12 but there is no best practice guid-
ance for doing so.
We set out to conduct a systematic review of published 
studies on the effectiveness of interventions to increase 
rates of referral and uptake from primary care or outpatient 
departments to exercise-based PR programs in patients with 
COPD compared to standard care, alternative interventions, 
or no intervention.
Methods
Recognized systematic review methods15 were adapted to 
conduct the review. The review protocol was registered 
on PROSPERO (2016:CRD42016043762)16 and reported 
according to PRISMA guidelines.17
eligibility
Studies were required to report at least one of the main out-
comes of interest: rates of referral to or uptake of exercise-
based PR programs in patients with COPD. We defined PR 
programs as including “multicomponent, multidisciplinary 
interventions, which are tailored to the individual patient’s 
needs. The rehabilitation process should incorporate a pro-
gram of physical training, disease education, and nutritional, 
psychological, and behavioral intervention.”18 Uptake was 
defined as having attended a first appointment with a PR 
provider including initial assessment.
We included all studies that used established quantita-
tive or mixed methods of data collection, eg, trials, surveys, 
direct observations, action research, interviews, focus groups 
or questionnaires, systematic reviews, and meta-analyses. 
Interventions could be contrasted with standard care, alterna-
tive interventions, or have no comparator or control.
We included studies of i) healthcare professionals who 
referred COPD patients to PR in primary, secondary, or com-
munity care settings; ii) adult patients ($18 years) with a 
diagnosis of COPD in any setting, who had received a referral 
to PR (whether taken up or not); and iii) informal adult carers 
($18 years) of these patients, defined as spouse or partner, 
family members, friends, or significant others, who provided 
physical, practical, transportation, or emotional help to 
someone with COPD. We excluded professional carers. We 
also excluded studies that featured mixed participant groups 
where subgroups with COPD were not described or where 
studies were conducted in various settings and data from 
inpatient and outpatient services could not be separated.
Published studies were included. Conference abstracts 
and opinion papers were not considered for analysis. No 
language restrictions were applied.
Data sources and search strategy
We searched the following databases: MEDLINE and 
EMBASE (via OVID), CINAHL and PsycINFO (via Ebsco-
Host), ASSIA and BNI (via ProQuest), Web of Science, 
and Cochrane Library to the end of January 2018. A search 
strategy was developed on MEDLINE (see Supplementary 
material) and adapted for other databases. The strategy 
included “quantitative” OR “mix* method*.” Filters for 
randomized controlled trials (RCTs) and systematic reviews 
were adapted from Scottish Intercollegiate Guidelines 
Network search filters.19 We also searched “related article” 
searches in PubMed for all studies included in the review 
and scanned reference lists of all included studies and key 
references, searching for relevant papers citing the included 
papers in the Institute for Scientific Information Web of 
Science (Science Citation Index and Social Sciences Citation 
Index). An interim report of this work, searching literature up 
to June 2016 and without specific search criteria for quantita-
tive and mixed methods studies, was presented at the British 
Thoracic Society in 2016.20
Study selection and data extraction
Search results were screened on titles and abstracts and then 
on full text by two independent reviewers (FE and IW), 
gaining consensus on inclusion with input from a referee 
(JF) if required.
A data extraction form was piloted and two reviewers 
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Interventions to increase referral and uptake to pulmonary rehabilitation
papers. Data included study setting, sample size, recruitment 
method, study design, study objectives, participant/patient 
characteristics, methods of data collection, data analysis, 
recorded outcomes, limitations, and conflict of interests. We 
planned to tabulate data and carry out a meta-analysis using 
Review Manager ([RevMan], Version 5.3; The Cochrane 
Collaboration, The Nordic Cochrane Centre, Copenhagen, 
2014) statistical software according to our prespecified pro-
tocol if this was appropriate.
Quality assessment
The same reviewers independently appraised study quality to 
assess the risk of bias in individual studies using the Cochrane 
Collaboration’s tool for assessing risk of bias in RCTs,21 the 
ACROBAT-NRSI (A Cochrane Risk Of Bias Assessment 
Tool for Non-Randomized Studies of Interventions),22 and 
AMSTAR (A MeaSurement Tool to Assess systematic 
Reviews)23 depending on the type of study.
Results
Searches identified 5,328 potentially relevant articles of 
which 14 met our inclusion criteria (Figure 1). All were in 
English language. Six studies were conducted in the UK,24–29 
four in Denmark,30–33 two in Australia,34,35 and one in USA.36 
One was a systematic review.36 Study characteristics and 
findings are summarized in Table 1.
Ten studies included rates of referral to PR as an 
outcome24,25,27–33,36 of which eight24,27,29–33,36 reported the 
number of patients or patient records studied, in total 
44,720. This total included five large audits capturing data 
from 43,098 patient records (range 1,211–32,018).30–33,36 
Five studies assessed rates of uptake to PR of which three 
reported the number of patients studied, in total 1,426 (range 
126–600).26,34,35 One study reported only percentages.25 
A systematic review by Jones et al37 found no eligible studies 
of uptake.
Populations and settings
Descriptions of patient populations were limited. Age and 
sex were most commonly reported and no studies reported 
ethnicity. Age and sex were reported by six studies that mea-
sured referral24,27,30–33 and three that measured uptake.26,34,35 
The number and/or roles of clinicians involved were 
reported by seven studies that measured referral24,25,28,30,31,33,36 
and two that measured uptake.25,35 Overall, patients were 
older (mean age $69 years) and 44%–64% of the samples 
were males.




Additional records identified from
reference checking
(n=5)
Duplicate records removed (n=2,450)
Records excluded based on title and
abstract (n=5,309)
Excluded studies (n=5)
No measure of referral or uptake
(n=3)
No intervention (n=2)
Records remaining after duplicates were
removed
(n=5,328)
Full-text articles assessed for eligibility
(n=19)
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Study designs were heterogeneous and most were observa-
tional. Of the referral studies, two captured referral data at one 
time point only,24,25 six reported before and after longitudinal 
data,28,30–33,36 one reported before and after results using a 
historical comparison group,27 and one conducted a pragmatic 
non-RCT.29 Of the uptake studies, one captured uptake data 
at one time point only,25 one reported before and after results 
using a historical comparison group,26 one used a controlled 
before and after design,34 and there was one cluster RCT.35 
The systematic review by Jones et al37 searched for RCTs 
evaluating uptake and identified none.
Interventions
Most studies measured referral or uptake to PR in the con-
text of multifaceted evidence-based management of COPD. 
Only one study focused specifically on referral25 and one on 
uptake.26 Interventions ranged from clinician education to 
system-wide change.
Studies measuring referral in primary care included a 
computer-guided COPD review,24 educational programs 
for healthcare providers (HCPs),30,33 collaborative team-
based education and empowerment,36 an action research 
study which generated a range of interventions including 
education and memory aids,25 general practice networks 
with specialist support and financial incentives,28 and a 
patient-held scorecard comparing the patient’s own care 
against care quality indicators.29 Secondary care interven-
tions included education for HCPs,31 education for HCPs 
plus a discharge bundle,27 and quality monitoring through 
a clinical register.32 Studies measuring uptake included a 
group opt-in session for patients prior to PR assessment,26 
a patient-held manual summarizing evidence on COPD treat-
ments with questions to ask the physician,34 individualized 
care planning supported by partnership working between 
general practitioners (GPs) and nurses,34 and the action 
research study by Foster et al.25
Referral was reported at the level of individual patients,24 
practice/department,25,29,36 and system level or GP network.28–33 
Uptake was reported at individual patient levels.26,34,35
Table 1 illustrates the range of characteristics of the studies. 
Primary care was the most common setting. Most interven-
tions targeted clinicians. Patients were targeted in two studies 
measuring referral27,29 and three measuring uptake.26,34,35 Two 
interventions were at the level of healthcare systems, both 
measuring referral.28,32 Education and learning support were 
the most common features of interventions that targeted 
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Interventions to increase referral and uptake to pulmonary rehabilitation
studies measuring uptake had a comparison group design26,34,35 
compared to three out of 10 measuring referral.27–29 All studies 
of interventions that included elements aimed at patients had 
a comparison group design.26,27,29,34,35
Outcomes
Referral to PR was the main outcome in eight out of 10 
studies24,25,27–29,31,32,36 and uptake was the main outcome in 
three out of four studies.25,26,34 There was limited detail 
about procedures for data collection. Most referral outcomes 
were measured by audits of patient records.25,28–33,36 Graves 
et al,26 Harris et al,34 and Zwar et al35 measured uptake for 
individual patients though terms such as “enrollment”34 and 
“attendance”25 were not defined. Foster et al25 asked patients 
about their decision to attend PR in a survey.
Conflicts of interest
Potential conflicts of interest were noted in four studies 
where the authors developed and owned the computer soft-
ware being assessed24 and where consultants from funding 
organizations were involved in intervention delivery and 
quality control.30,31,33
Assessment of methodological quality of 
included studies
All studies had areas of high risk of bias. In the RCT by 
Zwar et al,35 this related to the unavoidable lack of blind-
ing of participants (Table 2). The risk of attrition bias was 
unclear. Furthermore, 52 out of 234 patients allocated to 
the intervention group did not receive the intervention. No 
reasons were given for this and the risk of bias is unclear in 
this regard (Other bias in Table 2). All remaining studies were 
considered to have a high risk of bias due to a critical risk 
of confounding that was associated with the study designs 
(Table 3). The systematic review by Jones et al37 was of high 
methodological quality (Table 4).
Study findings
Due to study heterogeneity, we considered it inappropriate 
to summarize results using a meta-analysis. The reported 
outcomes can only be understood in the context of each study 
and are not readily comparable across studies. Furthermore, 
when considering the study outcomes in light of the various 
characteristics shown in Table 5 there were no discernible 
patterns to link study characteristics and outcomes.
Referral to PR
Four studies reported statistically significant increases 
in PR referral. In primary care, Roberts et al29 reported 
an increase for the intervention group following use of a 
patient-held quality scorecard, which was 6.1% (P=0.03) 
greater than that for the control group. Following a col-
laborative model of education and change implementation, 
mean referral to PR across 16 general practices increased 
by 5% (from 7% to 12%) (P=0.048),36 and a 3.5% increase 
in referrals (from 16.7% to 20.2%) (P,0.01) followed an 
education program in primary care.30 Tøttenborg et al32 
reported a 36% increase in referrals (from 55% to 91%) 
(relative risk 2.78, 95% CI, 2.65; 2.90) across hospital 
outpatient departments during mandatory monitoring of 
quality indicators.
Positive but statistically nonsignificant results followed 
an educational program in primary care33 and an educa-
tion program across outpatient departments.31 Two studies 
reported increases based on descriptive data following use 
of a COPD discharge care bundle in a hospital ward27 and 
a quality improvement intervention across primary care.28 
A computer-guided COPD review24 and an action research 
study25 did not collect comparative data.
Uptake of PR
Two studies reported statistically significant increases in 
uptake. Harris et al34 evaluated a patient manual summarizing 
evidence on COPD treatments and reported an increase 
of 18% in PR enrollment among participants in the most 
socioeconomically disadvantaged stratum compared to no 
increase in the matched control group (P=0.05). Zwar et al35 
reported a 21.5% difference in the number of intervention 
group patients attending PR (P=0.002) compared to controls 
where the intervention group had received an individualized 
care plan supported by partnership working between nurses 
and GPs.
Table 2 Risk of bias assessment (Cochrane RCT) for randomized studies

























Zwar et al35 Low Low High Unclear Low Low Unclear
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One study did not collect comparative data25 and a statisti-
cally significant decrease in uptake followed a group opt-in 
patient information session compared to usual care (58.7% 
vs 75%, P,0.001).26
Discussion
Our carefully conducted systematic review identified a het-
erogeneous group of studies. Most reported some positive 
results but only six out of 14 demonstrated statistically 
significant improvements. Statistically significant increases 
in referral followed educational sessions for clinicians in 
primary care,30 collaborative learning sessions for HCPs,36 
use of a patient-held COPD care scorecard in primary care,29 
and continuous monitoring of care quality indicators in 
hospital settings.32 Statistically significant increases in uptake 
followed use of a patient-held summary of COPD research 
evidence in secondary care34 and a nurse/GP partnership 
model of care.35 Significantly fewer patients who attended a 
group opt-in information session subsequently attended PR 
assessment compared to patients for whom no opt-in session 
was offered, although subsequent completion rates improved 
among those who attended.26 Only three studies focused 
specifically on referral25 or uptake26,37 and we are unable 
to accurately evaluate the impact of a targeted approach to 
increase referral or uptake to PR.
The potential for generalizability from the studies is 
limited by four factors. Firstly, most study designs carried 
areas of high risk of bias. Secondly, some interventions 
were not well defined. For example, in two studies the terms 
“enrollment”34 and “attendance”35 were not explained and it 
was not possible to distinguish between attendance at pre-
course assessment and the first PR class, which are separate 
stages in the PR pathway. Thirdly, there was limited reporting 
of patient and clinician populations which may be potentially 
nonrepresentative. Fourthly, the studies were conducted in 
high income countries and there were no interventions in 
low-to-middle income countries where over 90% of deaths 
globally from COPD occur.2
Two of the studies performed spirometry and confirmed 
a COPD diagnosis in 57.8%35 and 81%24 of patients. Jones 
et al37 included only participants with a diagnosis of COPD 
confirmed by spirometry in their systematic review and iden-
tified no studies of uptake. Evidence shows that patients on 
COPD registers do not always have a confirmed diagnosis 
with proportions varying from 73%38 to 90%.39 The question 
remains as to whether this is problematic for drawing con-
clusions from intervention studies. If studies do not confirm 
a COPD diagnosis it is possible that the COPD population 
Table 4 Quality assessment of Jones et al37 against the AMSTAR 
(A MeaSurement Tool to Assess systematic Reviews) measure-
ment tool”
was an “a priori” design provided? Yes
was there duplicate study selection and data extraction? Yes
was a comprehensive literature search performed? Yes
was the status of publication (ie, gray literature) used as an 
inclusion criterion?
Yes
was a list of studies (included and excluded) provided? Yes
were the characteristics of the included studies provided? Yes
Was the scientific quality of the included studies assessed and 
documented?
Yes
Was the scientific quality of the included studies used 
appropriately in formulating conclusions?
Yes
Were the methods used to combine the findings of studies 
appropriate?
N/a
was the likelihood of publication bias assessed? Yes
Was the conflict of interest stated? Yes
Table 3 Cochrane Risk of Bias Assessment Tool for nonrandomized studies of interventions (ACROBAT-NRSI)



















Bias in selection 
of the reported 
results
Angus et al24 Critical Serious Serious Serious Serious Moderate Moderate
Deprez et al36 Critical Serious Low No information Moderate Moderate Low
Foster et al25 Critical Serious Serious Serious Serious Moderate Moderate
Graves et al26 Critical Low Low Serious Low Moderate Moderate
Harris et al34 Critical Serious Low Moderate Moderate Moderate Moderate
Hopkinson et al27 Critical Serious Low Serious Low Moderate Moderate
Hull et al28 Critical Moderate Serious Moderate Low Moderate Moderate
Lange et al30 Critical Serious Low Moderate Moderate Moderate Moderate
Lange et al31 Critical Serious Low Moderate Moderate Moderate Moderate
Roberts et al29 Critical Serious Low Moderate Moderate Moderate Moderate
Tøttenborg et al32 Critical Low Low Moderate Moderate Moderate Moderate














































































Powered by TCPDF (www.tcpdf.org)
                               1 / 1





























































































































































































































































































































































































































































































































































































Powered by TCPDF (www.tcpdf.org)
                               1 / 1





is overestimated and that effect sizes are therefore over or 
underestimated. However, Zwar et al35 provided a pragmatic 
argument for including patients with a clinical diagnosis 
of COPD that did not require confirmation by spirometry, 
indicating that this reflects practice in primary care, where 
diagnosis is often made and treatment initiated on clinical 
grounds.
Strengths and limitations
Strengths of this review are the use of recognized systematic 
methods and a search without language or date restriction, 
which reduced the risk of bias in conducting the review. 
A limitation is that it was not possible to verify the content 
of the reported PR programs to ensure that they matched the 
definition adopted for this review.18 Due to heterogeneity 
among the studies and poor quality assessments relative to 
evidence-based medicine quality criteria it is not possible to 
provide clear evidence-based recommendations for practice. 
The scope of this review, inclusive of different study designs, 
provides a novel and broad insight into the extent and type 
of evidence in the field and can provide a useful stimulus for 
intervention developers and researchers.
Comparison with other studies
Our review supplements that of Jones et al37 by including a 
broad range of study designs and not requiring spirometry-
confirmed diagnosis. A Cochrane review of referral, uptake, 
and adherence to PR has been registered recently and will 
add knowledge to this field.40
Whilst we cannot draw clear conclusions from our review 
about the efficacy of the interventions to increase referral and 
uptake to PR, these studies do address some of the known 
barriers and facilitators to referral and uptake.
Referral is impacted by accessibility of PR programs, 
HCPs’ knowledge of who and how to refer, the administra-
tive burden of making a referral, successful previous refer-
ral of other patients, the influence of the referring doctor 
(either positive or negative), and by patients knowing what 
PR involves and how it will help their health.41 Interven-
tions in this review supported clinicians through education 
and guidance to improve their knowledge of referral and 
PR,24,25,27,28,30,31,33,36 use of reminders and prompts,24,25 and the 
inclusion of PR referral in a discharge care bundle.27 Educa-
tion and learning support were the most common features of 
interventions directly targeting clinicians though it is unclear 
whether the education programs addressed the nature of the 
conversation between the HCP and the patient about PR refer-
ral or supported clinician skills in this regard. None of the 
interventions addressed accessibility of PR programs and it 
can only be assumed that sufficient capacity was available.
Barriers to patient uptake include transport and 
location,42–44 inconvenient timing,42,44 disruption to routine/
other priorities,41–43 influence of the referring doctor,42 lack 
of explanation of benefits,44 lack of perceived benefit,41,42,44 
believing oneself to be too disabled44 or that one’s conditions 
is not serious enough,41,44 negative past experience with PR 
or exercise,44 and burden of COPD and other health condi-
tions.41 Reasons for attending include a trusted, enthusiastic 
doctor who explained the benefits, perceived increased 
severity of the condition, perceiving that PR would help 
increase control and independence and improve health, and 
perceived social benefits.44 Positive reinforcement of PR by 
HCPs during the referral process is important.41 The study by 
Zwar et al,35 in which attendance at PR increased, provided 
individualized care plans and nurse support in patients’ 
homes, a model which could accommodate a personalized 
discussion over time about the benefits of PR to the patient 
and presumably establish a trusting relationship. However, 
Zwar et al35 noted that although more patients in the interven-
tion group attended PR this was still less than a third of the 
group. Interestingly, the information session provided in the 
study by Graves et al,26 which informed patients about the 
benefits of PR, was associated with reduced attendance at 
assessment but did improve attendance of those who started 
PR. Whilst perhaps not providing motivational support for 
patients who were unsure about attending, it could neverthe-
less improve service efficiency and highlights the importance 
of considering the whole PR pathway. The manual of COPD 
evidence-based treatments provided by Harris et al34 was 
helpful for more socioeconomically disadvantaged patients 
and may have facilitated a constructive clinician–patient 
interaction for this group. The authors also noted that more 
patients in this group reported actually using the manual, 
which would clearly influence any impact assessment. This 
highlights the need for good understanding of how interven-
tions work as well as whether they work. Practical factors 
such as transport, travel, and timing were not addressed by 
the interventions.
Strategies to improve referral and uptake have also been 
studied in cardiac rehabilitation (CR) with some success. 
A systematic review of interventions to promote uptake 
and adherence in CR reported improvements in eight out of 
10 studies of uptake but, as in our review, the authors could 
not make clear practice recommendations due to heterogene-
ity and risk of bias in the studies.45 Another systematic review 
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studies of referral and 13 studies of enrollment in the US, 
Canada, and the UK.46 The highest rates of referral (up to 
85%) were found in studies that implemented automatic 
referral orders (eg, from healthcare records or data) whereas 
the highest rates of enrollment (up to 86%) were achieved 
with a combination of automatic and liaison methods, includ-
ing discussion with an HCP. Enrollment and uptake to CR 
can also be improved by referral and structured follow-up 
by nurses or therapists and early outpatient education.45,47,48 
Whether findings from CR might be translated to PR is 
worthy of further research. The rehabilitation pathway dif-
fers for CR because referrals typically occur at the time of 
hospitalization for an acute event or procedure, whereas in 
the UK, for example, most PR referrals occur in primary care 
at the time of stable disease.13
Implications for practice and research
There is a call to provide recommendations to increase the 
delivery of PR worldwide to validate novel techniques for 
doing so, and to enhance evidence-based policy.12 While 
more evidence is needed to establish the efficacy and effec-
tiveness of different approaches, the studies reviewed here 
provide a useful platform for further work. The variety of 
interventions they represent, from one-off information ses-
sions to system-wide improvement projects, reflects the 
complex nature of COPD care management and the potential 
value of a range of evidence building approaches.
Firstly, there is an urgent need for high quality study 
designs to determine the efficacy, effectiveness, and causal 
mechanisms of interventions. There is a lack of evidence 
from RCTs and we identified only one ongoing RCT to test 
a method not previously evaluated: a video to increase PR 
uptake following hospitalized exacerbations of COPD.49 
Whilst RCTs are the gold standard for establishing a gen-
eralizable evidence base, they may not be the only relevant 
evaluation design in this field. There is a need to recognize 
contextual factors and the diversity of PR delivery and set-
tings across the world.50 In this regard, quality improvement 
approaches are well suited to learn what works in a local 
context, particularly where rapid testing of novel interven-
tions is needed. In contrast to research methods which aim to 
generate new knowledge, the aim of these approaches is to 
achieve positive and practical change in an identified service 
through focus on a well-defined problem.51 These methods 
are accessible to service providers in “real-world” settings. 
Two studies reviewed here, Hull et al28 and Hopkinson et al,27 
utilized quality improvement methods. In addition, for the 
researcher, realist approaches that seek to identify what 
works, in which circumstances, and for whom could help to 
recognize and accommodate contextual complexity within 
the evaluation design and provide more transferable learning 
about the impact of contextual factors.52 Such methods have 
value in real-world settings where multiple variables cannot 
be controlled.
Secondly, there is a need to improve reporting of study 
populations as a factor to enhance external validity. Results 
from Harris et al34 suggest differential effects across sub-
groups of patients and this is worthy of further investigation. 
None of the studies in this review reported the ethnicity of 
patients. In an area of East London in the UK members of 
some Black and minority ethnic populations have lower rates 
of referral to PR compared to White patients53 and there is a 
need to understand more about how to support PR access in 
ethnically diverse communities. There may also be specific 
issues in resource poor countries54 which are not represented 
among the studies in this review.
Thirdly, in their study of a group opt-in session prior to 
assessment, Graves et al26 reported that, despite no impact on 
uptake, fewer intervention patients who started PR dropped 
out for reasons other than illness and significantly more 
graduated. This indicates the importance of considering the 
whole PR pathway. Following the patient through the entirety 
of their PR journey will lead to a greater understanding of 
how to improve service efficiency. Only two studies in this 
review intervened at the system level28,32 and there is scope 
for more research in this area. More studies measured refer-
ral than uptake and more patients were included in referral 
studies than in uptake studies, suggesting a differential focus 
on these two stages.
Fourthly, interventions may benefit from theory-based 
design. Cox et al41 used the Theoretical Domains Frame-
work to analyze factors affecting referral and participation 
in PR and we have highlighted above how some of the 
reviewed studies addressed these factors, although it was 
not possible to asses this accurately without access to more 
detailed intervention descriptions. However, we believe 
that the work by Cox et al41 provides a useful theoretical 
framework for intervention designers. Interventions could 
focus on specific constructs that have been shown to have 
relevance and then assess the impact on those constructs 
to generate a theoretically informed understanding of what 
works and why.
Conclusion
This review demonstrates the broad range of approaches 
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and secondary care. Some positive results have been demon-
strated but there is limited generalizable evidence because 
interventions and methods are heterogeneous and descrip-
tions of populations are limited. Further theory-based testing 
of promising interventions using robust methods in various 
populations and settings is required to draw clear conclu-
sions about how to optimize access to PR across a range of 
settings.
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1 (((pulmonary rehabilitation.ti,ab.) or (((emphysema or 
copd or chronic obstructive pulmonary disease or chronic 
bronchitis or chronic asthma).ti,ab. or exp Pulmonary 
Disease, Chronic Obstructive/ or exp Bronchitis, Chronic/ 
or exp Asthma/ or exp Emphysema/) and ((exercis* or 
rehab* or physiotherap* or “physical therap*”).ti,ab. or 
exp Exercise Therapy/ or exp Exercise/ or exp rehabilita-
tion/ or exp Physical Therapy Modalities/))) and ((refer* 
1 or referring or referred or referral* or assess*).ti,ab. Or 
exp “Referral and Consultation”/) And ((rate* or num-
ber* or audit* or percentage or barrier* or facilitat* or 
frequen* or infrequent* or rare* or common* or uncom-
mon or standard* or influenc* or reluctant* or barrier* 
or obstacle or (meet* adj3 criter*)).ti,ab. Or exp practice 
patterns, physicians/ or exp guideline adherence or exp 
data collection/))
2 ((pulmonary rehabilitation.ti,ab.) or (((emphysema 
or copd or chronic obstructive pulmonary disease or 
chronic bronchitis).ti,ab. or exp Pulmonary Disease, 
Chronic Obstructive/ or exp Bronchitis, Chronic/ or exp 
Emphysema/) and ((exercis* or rehab* or physiotherap* 
or “physical therap*”).ti,ab. or exp Exercise Therapy/ 
or exp Exercise/ or exp rehabilitation/ or exp Physical 
Therapy Modalities/))) and ((uptake or up-take or (up 
adj3 take*) or non-attend* or nonattend* or attend* or 
engag* or (treat* adj3 refus*) or decline* or concordan* 
or complian* or barrier* or obstacle* or adher* or 
accept*).ti,ab. Or exp treatment refusal/ or exp patient 
compliance/ or exp patient acceptance of healthcare/)
3 1 or 2
4 ((((Meta-Analysis as Topic/ or Meta-Analysis/ or 
exp Review Literature as Topic/) or ((meta analy$) 
or (metaanaly$) or ((systematic adj (review$1 or 
overview$1)))).tw. or (Cochrane or embase or psychlit 
or psyclit or psychinfo or psycinfo or cinahl or cinhal 
or (science citation index) or bids or cancerlit or refer-
ence list$ or bibliograph$ or hand-search$ or (relevant 
journals) or (manual search$)).ab. or ((selection criteria 
or data extraction).ab. and review/)) NOT (Comment/ or 
Letter/ or Editorial/)) Or (((Randomized Controlled Tri-
als as Topic/ or randomized controlled trial/ or Random 
Allocation/ or Double Blind Method/ or Single Blind 
Method/ or clinical trial/ or exp Clinical Trials as topic/ 
or PLACEBOS/) or ((clinical trial, phase i) or (clinical 
trial, phase ii) or (clinical trial, phase iii) or (clinical 
trial, phase iv) or (controlled clinical trial) or (random-
ized controlled trial) or (multicenter study) or (clinical 
trial)).pt or ((clinical adj trial$) or ((singl$ or doubl$ or 
treb$ or tripl$) adj (blind$3 or mask$3)) or (placebo$) 
or (randomly allocated) or (allocated adj2 random$)).tw) 
NOT (case report.tw or letter/ or historical article/))) or 
(quantitative or (mix* adj method*)).mp.
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